Standard product specifications have now been produced for all the CQUIN1 dose banded chemotherapy drugs. This document asks stakeholders to comment generally on the following aspects (i.e. whether in agreement with the criteria or not, and whether anything has been overlooked?)
User guide documents for the set of dose banded chemotherapy standardised product specifications to support the production and supply of ready-made chemotherapy medicine.
Background information on the set of dose banded chemotherapy standardised product specifications to support the production and supply of ready-made chemotherapy medicine.
This policy document outlines the arrangements for funding of Bortezomib for relapsed/refractory mantle cell lymphoma.
This monthly release aims to provide users with an overview of NHS performance statistics in key areas. Official statistics are designed to give informative and impartial information about the performance of the NHS. It identifies a 1.8 per cent growth in the
Report that finds while outcomes for breast cancer are good and improving, overall progress is disguising variations across the country. Some women are being diagnosed at an earlier stage of their breast cancer than others, greatly improving their chances of survival. Some women
Report that identifies that additional research is needed and funders stand ready to invest more in brain tumour research. It finds: An effective way of growing research capacity and capability at all career stages, including senior research leadership, is to establish dedicated
This debate pack outlines the progress so far in implementing the Achieving World-class Cancer Outcomes: A Strategy For England 2015-2020: Report of the Independent Cancer Taskforce strategy and provides statistics on survival rates and the NHS cancer workforce. Finally, this paper pulls
National Strategy for Cancer that emphasises the importance of earlier diagnosis and of living with and beyond cancer in delivering outcomes that matter to patients. The report recognises that no two patients are the same, either in their cancer or their healthand care needs.
Case study from the University of Southampton, explaining how the TrueNTH the Supported Self-Management and Follow-Up Care programme, established by the Movember Foundation is improving the lives and experiences of men living with prostate cancer. Finds that patients have benefitted from
This guideline covers diagnosing and managing pancreatic cancer in adults aged 18 and over. It aims to improve care by ensuring quicker and more accurate diagnosis, and by specifying the most effective treatments for people depending on how advanced their
Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery in adults.
Evidence-based recommendations on ibrutinib (Imbruvica) for treating relapsed or refractory mantle cell lymphoma in adults.
Evidence-based recommendations on fulvestrant (Faslodex) for treating locally advanced or metastatic (secondary), oestrogen-receptor positive breast cancer in postmenopausal women who have not had endocrine therapy before.
All-Parliamentary Group on Blood Cancer report that makes important recommendations on how to make improvements and ensure that we all work together to raise awareness of blood cancer. It is also a call to the Government and NHS to ensure
Evidence-based recommendations on lenvatinib (Kisplyx) with everolimus for previously treated advanced renal cell carcinoma in adults.
Evidence-based recommendations on ceritinib (Zykadia) for untreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer in adults.
Executive summary of quality assurance (QA) visit to North East London Bowel Cancer Screening Centre held on 17 March 2017. The QA visit team identified 9 high priority findings as summarised below: Barts Health NHS Trust does not have an agreed
Executive summary of quality assurance (QA) visit to Gloucestershire Breast Screening Service held on 27 September 2017. The QA visit team identified 8 high priority findings as summarised below: the current staffing for breast care nurses does not meet nursing guidelines for
Kent and Medway Cancer Alliance Report that aims to give care providers and policy makers an insight into the burden of cancer – measured in terms of the number of people affected, deaths and survival. They also comment on some